Moderna
MRNA
MRNA
976 hedge funds and large institutions have $34.3B invested in Moderna in 2022 Q2 according to their latest regulatory filings, with 99 funds opening new positions, 346 increasing their positions, 354 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
976
Holders Change
-25
Holders Change %
-2.5%
% of All Funds
16.5%
Holding in Top 10
23
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.39%
New
99
Increased
346
Reduced
354
Closed
110
Calls
$5.06B
Puts
$2.32B
Net Calls
+$2.74B
Net Calls Change
-$528M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$624M |
| 2 |
Goldman Sachs
New York
|
$396M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$485M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$3.95B |
| 5 |
Morgan Stanley
New York
|
$497M |
Top Sellers
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
$1.84B |
| 2 |
BlackRock
New York
|
$3.75B |
| 3 |
Renaissance Technologies
New York
|
$312M |
| 4 |
D.E. Shaw & Co
New York
|
$3.83M |
| 5 |
Coatue Management
New York
|
$815M |
